Literature DB >> 9486003

Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells.

A Sabokbar1, Y Fujikawa, S Neale, D W Murray, N A Athanasou.   

Abstract

OBJECTIVE: In aseptic loosening, a heavy macrophage response to biomaterial wear particles is commonly found in arthroplasty tissues. The aim of this study was to discover if these cells contribute to the bone resorption of aseptic loosening by differentiating into osteoclasts.
METHODS: Macrophages were isolated from the pseudocapsule and pseudomembrane of loose cemented and uncemented hip arthroplasties at the time of revision surgery and then co-cultured on glass coverslips and dentine slices with UMR 106 rat osteoblast-like cells, both in the presence and absence of 1,25 dihydroxyvitamin D3 [1,25(OH)2D3]. Macrophages isolated from the synovial membrane of patients with osteoarthritis (OA) undergoing hip replacements were similarly studied as a control group.
RESULTS: After 24 hours incubation, most cells isolated from the above periprosthetic tissues strongly expressed macrophage (CD11b, CD14) but not osteoclast markers. However, after 14 days incubation, numerous multinucleated cells showing the phenotypic features of osteoclasts (that is, positive for tartrate resistant acid phosphatase, the vitronectin receptor, and capable of extensive lacunar resorption) formed in co-cultures of arthroplasty derived macrophages and UMR 106 cells, in the presence of 1,25(OH)2D3. The addition of an antibody to macrophage colony stimulating factor (M-CSF) considerably reduced macrophage-osteoclast differentiation and hence the lacunar resorption seen in these co-cultures. In contrast, OA synovial macrophage/UMR 106 co-cultures showed little or no evidence of macrophage-osteoclast differentiation and this was only seen when human M-CSF was added to the co-cultures.
CONCLUSION: This is the first report showing that human macrophages isolated directly from periprosthetic tissues surrounding loosened implants can differentiate into multinucleated cells showing all the functional and cytochemical characteristics of osteoclasts. In contrast with other macrophage populations, exogenous M-CSF is not required for this to occur. In the context of the heavy macrophage response to wear particles in periprosthetic tissues macrophage-osteoclast differentiation may represent an important cellular mechanism whereby osteolysis is effected in aseptic loosening.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9486003      PMCID: PMC1752416          DOI: 10.1136/ard.56.7.414

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  38 in total

Review 1.  Pathologic studies of total joint replacement.

Authors:  P G Bullough; E F DiCarlo; K K Hansraj; M C Neves
Journal:  Orthop Clin North Am       Date:  1988-07       Impact factor: 2.472

2.  Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

Authors:  N Takahashi; H Yamana; S Yoshiki; G D Roodman; G R Mundy; S J Jones; A Boyde; T Suda
Journal:  Endocrinology       Date:  1988-04       Impact factor: 4.736

3.  Tissue reactions to joint prostheses and the products of wear and corrosion.

Authors:  P A Revell
Journal:  Curr Top Pathol       Date:  1982

4.  Failure of cells of the mononuclear phagocyte series to resorb bone.

Authors:  T J Chambers; M A Horton
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

5.  Resorption of dentine by isolated osteoclasts in vitro.

Authors:  A Boyde; N N Ali; S J Jones
Journal:  Br Dent J       Date:  1984-03-24       Impact factor: 1.626

6.  The human osteoclast precursor circulates in the monocyte fraction.

Authors:  Y Fujikawa; J M Quinn; A Sabokbar; J O McGee; N A Athanasou
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

7.  Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.

Authors:  Y Fujikawa; A Sabokbar; S Neale; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

8.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.

Authors:  M A Horton; D Lewis; K McNulty; J A Pringle; T J Chambers
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

9.  A histologic comparison of aseptic loosening of cemented, press-fit, and biologic ingrowth prostheses.

Authors:  D W Lennox; B H Schofield; D F McDonald; L H Riley
Journal:  Clin Orthop Relat Res       Date:  1987-12       Impact factor: 4.176

10.  Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.

Authors:  C Minkin
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

View more
  35 in total

1.  [Proposal for the classification of the periprosthetic membrane from loosened hip and knee endoprostheses].

Authors:  L Morawietz; Th Gehrke; R-A Classen; B Barden; M Otto; T Hansen; Th Aigner; P Stiehl; J Neidel; J H Schröder; L Frommelt; Th Schubert; C Meyer-Scholten; A König; Ph Ströbel; Ch P Rader; S Kirschner; F Lintner; W Rüther; A Skwara; I Bos; J Kriegsmann; V Krenn
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

2.  The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption.

Authors:  A Sabokbar; R Pandey; N A Athanasou
Journal:  J Mater Sci Mater Med       Date:  2003-09       Impact factor: 3.896

3.  Effects of synovial fluid from aseptic prosthesis loosening on collagen production in osteoblasts.

Authors:  Jon A Tsai; Martin K Andersson; Mikael Ivarsson; Barbro Granberg; André Stark
Journal:  Int Orthop       Date:  2008-03-19       Impact factor: 3.075

4.  Expansion of CD14+CD16+ peripheral monocytes among patients with aseptic loosening.

Authors:  W Wu; X Zhang; C Zhang; T Tang; W Ren; K Dai
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

Review 5.  Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.

Authors:  Donald W Howie; Susan D Neale; David R Haynes; Oksana T Holubowycz; Margaret A McGee; Lucian B Solomon; Stuart A Callary; Gerald J Atkins; David M Findlay
Journal:  Inflammopharmacology       Date:  2013-10-15       Impact factor: 4.473

6.  Characteristics of highly cross-linked polyethylene wear debris in vivo.

Authors:  Ryan M Baxter; Daniel W MacDonald; Steven M Kurtz; Marla J Steinbeck
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2013-02-22       Impact factor: 3.368

7.  Surface modification of implant materials and its effect on attachment and proliferation of bone cells.

Authors:  Hak-Kwan Kim; Ju-Woong Jang; Chang-Hee Lee
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

8.  Alpha-calcitonin gene-related peptide can reverse the catabolic influence of UHMWPE particles on RANKL expression in primary human osteoblasts.

Authors:  Max D Kauther; Jie Xu; Christian Wedemeyer
Journal:  Int J Biol Sci       Date:  2010-09-15       Impact factor: 6.580

9.  In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic mice.

Authors:  Kunihiko Takahashi; Shin Onodera; Harukazu Tohyama; Hyuck Joon Kwon; Ken-ichi Honma; Kazunori Yasuda
Journal:  J Biomed Biotechnol       Date:  2010-09-21

10.  The role of oxidative stress in aseptic loosening of total hip arthroplasties.

Authors:  Marla J Steinbeck; Lauren J Jablonowski; Javad Parvizi; Theresa A Freeman
Journal:  J Arthroplasty       Date:  2013-11-26       Impact factor: 4.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.